High-resolution MHC sequencing reveals novel genetic risk variants underlying antithyroid drug-induced agranulocytosis.
- DOI
- 10.1210/clinem/dgag359
- Published
- 2026 Oct 27
- Container
- The Journal of clinical endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1210/clinem/dgag359,
title = {High-resolution MHC sequencing reveals novel genetic risk variants underlying antithyroid drug-induced agranulocytosis.},
author = {Miao X and Jiang Y and Zhao M and Luo Y and Gong X and Guo X and Tan B and Yan C and Zhang B and Li SC and He Y},
year = {2026},
journal = {The Journal of clinical endocrinology and metabolism},
doi = {10.1210/clinem/dgag359},
url = {https://doi.org/10.1210/clinem/dgag359}
}RIS
TY - JOUR TI - High-resolution MHC sequencing reveals novel genetic risk variants underlying antithyroid drug-induced agranulocytosis. AU - Miao X AU - Jiang Y AU - Zhao M AU - Luo Y AU - Gong X AU - Guo X AU - Tan B AU - Yan C AU - Zhang B AU - Li SC AU - He Y PY - 2026 JO - The Journal of clinical endocrinology and metabolism DO - 10.1210/clinem/dgag359 UR - https://doi.org/10.1210/clinem/dgag359 ER -
APA
X, M., Y, J., M, Z., Y, L., X, G., X, G., B, T., C, Y., B, Z., SC, L., & Y, H. (2026). High-resolution MHC sequencing reveals novel genetic risk variants underlying antithyroid drug-induced agranulocytosis.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag359
Source records
- pubmed · retrieved 2026-11-10T14:33:24.330Z